Page 2 - Clinical Development Services News Today

In this article, we discuss George Soros stock portfolio: top 10 stock picks.

Sponsors of psychiatric clinical trials may face significant challenges in collecting robust, quality data to support the efficacy and safety of...

/PRNewswire/ -- As the number of next-generation oncology therapies in the clinical trial pipeline surges, Premier Research today announced three new oncology...

Bionomics BNC210 Expansion into Social Anxiety Disorder News provided by Share this article Share this article Rapid oral absorption of BNC210 novel tablet formulation ideally suited for acute treatment of anxiety in patients with Social Anxiety Disorder BNC210 Phase 2b PTSD trial on target for start in mid-2021 with U.S. CRO Premier Research selected and clinical site identification underway Pipeline expansion puts Company on path for two Phase 2 programs underway in 2021 ADELAIDE, Australia...

Syneos Health Leaders Recognized For Visionary Healthcare Expertise Through HBA Healthcare Businesswomen’s Association Shines a Light on Lynn Hamilton and Katya Magonova May 06, 2021 07:30 ET | Source: Syneos Health, Inc. Syneos Health, Inc. MORRISVILLE, N.C., May 06, 2021 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Lynn Hamilton, Senior Director, Clinical Operations and...

MedCity News Thermo Fisher’s $21B deal for PPD gives it missing piece in drug development cycle Thermo Fisher Scientific sells laboratory equipment used in drug research and it also offers manufacturing services for experimental and commercialized drugs. By acquiring PPD, Thermo Fisher says it will gain capabilities in the growing global market of clinical trial services. Shares0   Thermo Fisher Scientific sells the laboratory equipment that biopharmaceutical companies use in the research ...